Senior insider sale
EVOMMUNE, INC. — senior position signals high conviction
$205.2K
9.26K shares
What this filing means
COHEN DAVID E plans to sell 9.26K shares of EVOMMUNE, INC. valued at approximately $205.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/2/2026ACC: 0001950047-26-005513
9.26K
Shares to sell
$205.2K
Approx. market value
9.26K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Pre-IPO Purchase of Common Shares
N/A
6/23/2020
6.06KRestricted Stock Awards
N/A
5/29/2020
3.20KTotal acquired9.26K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/23/2020 | Pre-IPO Purchase of Common Shares N/A | 6.06K | — |
5/29/2020 | Restricted Stock Awards N/A | 3.20K | — |
| Total | 9.26K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
9.26K
Market value
$205.2K
6/2/2026
Total
Units
9.26K
Value
$205.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/2/2026 | 9.26K | $205.2K | NYSE | Planned |
| Total | 9.26K | $205.2K | ||